Pura Vida Investments’s DexCom DXCM Stock Holding History

Pura Vida Investments’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-57,200	Closed	-$5.34M	–	61
2023 Q3	$5.34M	Buy	57,200 +44,800	+361%	+$5.05M	1.01%	38
2023 Q2	$1.59M	Buy	+12,400	New	+$1.5M	0.21%	70
2022 Q3	–	Sell	-94,000	Closed	-$7.01M	–	217
2022 Q2	$7.01M	Buy	+94,000	New	+$8.58M	0.41%	67
2022 Q1	–	Sell	-173,200	Closed	-$23.3M	–	246
2021 Q4	$23.3M	Sell	173,200 -6,800	-4%	-$977K	0.84%	28
2021 Q3	$24.6M	Buy	180,000 +80,000	+80%	+$10.1M	0.75%	31
2021 Q2	$10.7M	Sell	100,000 -170,000	-63%	-$16.3M	0.33%	69
2021 Q1	$24.3M	Buy	270,000 +70,000	+35%	+$6.57M	0.69%	27
2020 Q4	$18.5M	Buy	200,000 +32,000	+19%	+$2.86M	0.67%	34
2020 Q3	$17.3M	Buy	+168,000	New	+$17.6M	0.89%	20
2018 Q1	–	Sell	-227,600	Closed	-$3.27M	–	75
2017 Q4	$3.27M	Buy	+227,600	New	+$2.96M	1.37%	28

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pura Vida Investments's DXCM Position: Q2 2024 in Review

Pura Vida Investments sold out of DexCom (DXCM) in Q2 2024, closing a stake of 30,000 shares — an estimated $4.16M sold.

Pura Vida Investments first reported a position in DXCM in Q1 2017 and held it in 23 quarters. The position peaked at $14.8M in Q3 2021. 1,000 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

Pura Vida Investments reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
Pura Vida Investments sold 30,000 DexCom shares in Q2 2024, an estimated $4.16M.
Pura Vida Investments first reported a position in DexCom in Q1 2017 and held it in 23 quarters.
Pura Vida Investments's DexCom position peaked at $14.8M in Q3 2021.
1,000 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Pura Vida Investments's 13F filing for Q2 2024, filed 14 Aug 2024.